The recent meteoric share price rise has been very nice but what will we see before the 4C is out?
- Another cap raise? (I realise they have a fair bit of cash but burn is still quite high IMO)
or
- Positive news on the early feasibility study design? (FDA sign off on the proposed study design?)
GLTAH
(Note: this is all pure conjecture I have nothing to base this on more than gut feel)
If there is another raise will retail get a sweetheart deal of discounted shares plus free options (or is that reserved for instos?)
The recent meteoric share price rise has been very nice but what...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.40 |
Change
0.000(0.00%) |
Mkt cap ! $353.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 741 | $18.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.59 | 200 | 2 |
View Market Depth
| Last trade - 10.18am 26/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable